ENOV
Enovis CorpNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.39B
P/E Ratio
—
EPS
$-19.89
Beta
1.52
52W High
$36.82
52W Low
$21.00
50-Day MA
$24.03
200-Day MA
$27.04
Dividend Yield
—
Profit Margin
-49.90%
Forward P/E
6.56
PEG Ratio
1.90
About Enovis Corp
Enovis Corporation is a global medical technology company. The company is headquartered in Wilmington, Delaware.
Fundamentals
| Revenue (TTM) | $2.28B |
| Gross Profit (TTM) | $1.39B |
| EBITDA | $372.25M |
| Operating Margin | 3.64% |
| Return on Equity | -55.30% |
| Return on Assets | 1.09% |
| Revenue/Share (TTM) | $39.83 |
| Book Value | $25.66 |
| Price-to-Book | 0.94 |
| Price-to-Sales (TTM) | 0.61 |
| EV/Revenue | 1.216 |
| EV/EBITDA | 22.42 |
| Quarterly Earnings Growth (YoY) | 153.10% |
| Quarterly Revenue Growth (YoY) | 5.40% |
| Shares Outstanding | $57.56M |
| Float | $56.59M |
| % Insiders | 1.57% |
| % Institutions | 119.66% |
Historical Volatility
HV 10-Day
74.76%
HV 20-Day
71.07%
HV 30-Day
69.47%
HV 60-Day
59.65%
HV Rank
97.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($43.00 target)
2
Strong Buy8
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026